Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Palliative transurethral resection of the prostate: functional outcome and impact on survival.
Marszalek M, Ponholzer A, Rauchenwald M, Madersbacher S. Marszalek M, et al. BJU Int. 2007 Jan;99(1):56-9. doi: 10.1111/j.1464-410X.2006.06529.x. Epub 2006 Oct 11. BJU Int. 2007. PMID: 17034496
Patients with prostate cancer in the pTURP specimen had a shorter 3-year survival (52%) than those with a negative histology (89%, P = 0.03). ...A repeat pTURP was necessary in 25% of patients, 11% required permanent catheterization and 10% were incontinent. …
Patients with prostate cancer in the pTURP specimen had a shorter 3-year survival (52%) than those with a negative histology ( …
The natural history of lower urinary tract symptoms over five years.
Temml C, Brössner C, Schatzl G, Ponholzer A, Knoepp L, Madersbacher S; Prostate Study Group of the Austrian Society of Urology. Temml C, et al. Eur Urol. 2003 Apr;43(4):374-80. doi: 10.1016/s0302-2838(03)00084-8. Eur Urol. 2003. PMID: 12667718
At the same time, all men underwent a health examination in 1996 and 2001. RESULTS: A total 456 men aged 52+/-12 years (range: 40-84) at baseline completed the 5-year follow-up. ...No change of IPSS was reported by 19%, a worsening by 50% and an improvement b …
At the same time, all men underwent a health examination in 1996 and 2001. RESULTS: A total 456 men aged 52+/-12 years (range: …
Frequent use of complementary medicine by prostate cancer patients.
Ponholzer A, Struhal G, Madersbacher S. Ponholzer A, et al. Eur Urol. 2003 Jun;43(6):604-8. doi: 10.1016/s0302-2838(03)00155-6. Eur Urol. 2003. PMID: 12767359
Urologists have to be aware of this fact and require a detailed knowledge on this issue to provide objective and evidence-based information....
Urologists have to be aware of this fact and require a detailed knowledge on this issue to provide objective and evidence-based infor …
Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients.
Marszalek M, Ponholzer A, Brössner C, Wachter J, Maier U, Madersbacher S. Marszalek M, et al. Urology. 2004 Jul;64(1):38-42. doi: 10.1016/j.urology.2004.02.007. Urology. 2004. PMID: 15245930 Review.
OBJECTIVES: To present our experience with elective, open, nephron-sparing surgery for renal masses in a contemporary, consecutive series. ...Renal cell carcinoma was present in 86 patients (66.7%), a benign cyst in 18 (13.9%), oncocytoma in 10 (7.8%), angiomyolipom …
OBJECTIVES: To present our experience with elective, open, nephron-sparing surgery for renal masses in a contemporary, consecutive se …
Holmium laser-enucleation of the prostate enables early catheter removal.
Madersbacher S, Marszalek M, Ponholzer A, Brössner C. Madersbacher S, et al. BJU Int. 2004 Oct;94(6):931-3. doi: 10.1111/j.1464-410X.2004.05062.x. BJU Int. 2004. PMID: 15476539 No abstract available.
Association between lower urinary tract symptoms and erectile dysfunction.
Ponholzer A, Temml C, Obermayr R, Madersbacher S. Ponholzer A, et al. Urology. 2004 Oct;64(4):772-6. doi: 10.1016/j.urology.2004.05.025. Urology. 2004. PMID: 15491718
In parallel, all men underwent a detailed health evaluation, including physical examination, evaluation of various lifestyle factors, and a blood laboratory study with 14 parameters. ...These findings have implications for the treatment of elderly men with LUTS and …
In parallel, all men underwent a detailed health evaluation, including physical examination, evaluation of various lifestyle factors, …
Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.
Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Ponholzer A, et al. Eur Urol. 2005 Jan;47(1):80-5; discussion 85-6. doi: 10.1016/j.eururo.2004.08.017. Eur Urol. 2005. PMID: 15582253
METHODS: Men aged 20-80 years participating in a health-screening project in the area of Vienna completed the IIEF-5 for evaluation of ED. In parallel, all men underwent a detailed health examination including physical assessment, evaluation of various life-style fa …
METHODS: Men aged 20-80 years participating in a health-screening project in the area of Vienna completed the IIEF-5 for evaluation o …
The effect on erectile function of 103palladium implantation for localized prostate cancer.
Ponholzer A, Oismüller R, Somay C, Büchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S. Ponholzer A, et al. BJU Int. 2005 Apr;95(6):847-50. doi: 10.1111/j.1464-410X.2005.05414.x. BJU Int. 2005. PMID: 15794796
OBJECTIVE: To determine in a prospective study the effect on erectile function of (103)Pd brachytherapy for localized prostate cancer, using a validated questionnaire. ...CONCLUSIONS: There was a high prevalence of pre-existing ED in these men; 57% of men ful …
OBJECTIVE: To determine in a prospective study the effect on erectile function of (103)Pd brachytherapy for localized prostate cancer …
Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
Temml C, Heidler S, Ponholzer A, Madersbacher S. Temml C, et al. Eur Urol. 2005 Oct;48(4):622-7. doi: 10.1016/j.eururo.2005.04.026. Eur Urol. 2005. PMID: 15964133
METHODS: Women and men participating in a health screening project in the area of Vienna completed the Bristol Lower Urinary Tract Symptoms (LUTS) questionnaire. ...OABwet had a more profound impact on quality of life. A negative impact of OAB on sexuality wa …
METHODS: Women and men participating in a health screening project in the area of Vienna completed the Bristol Lower Urinary Tract Sy …
Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls.
Marszalek M, Wachter J, Ponholzer A, Leitha T, Rauchenwald M, Madersbacher S. Marszalek M, et al. Eur Urol. 2005 Jul;48(1):34-9. doi: 10.1016/j.eururo.2005.03.020. Epub 2005 Apr 2. Eur Urol. 2005. PMID: 15967249
OBJECTIVE: Insulin-like growth factor 1 (IGF-1) and chromogranin A (CGA) are currently discussed as supplemental serum markers for prostate cancer (PC) diagnosis. ...METHODS: A consecutive series of 156 men (median age: 67 yrs) with newly diagnosed, untreated PC and …
OBJECTIVE: Insulin-like growth factor 1 (IGF-1) and chromogranin A (CGA) are currently discussed as supplemental serum markers for pr …
81 results
Jump to page
Feedback